-
881por Chaguza, Chrispin, Andam, Cheryl P., Harris, Simon R., Cornick, Jennifer E., Yang, Marie, Bricio-Moreno, Laura, Kamng’ona, Arox W., Parkhill, Julian, French, Neil, Heyderman, Robert S., Kadioglu, Aras, Everett, Dean B., Bentley, Stephen D., Hanage, William P.“…Streptococcus pneumoniae causes a high burden of invasive pneumococcal disease (IPD) globally, especially in children from resource-poor settings. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
882por Mathai, Dilip, Shamsuzzaman, Abul Khair Mohammad, Feroz, Ahrar Ahmed, Virani, Amin R, Hasan, Ashfaq, Ravi Kumar, KL, Ansari, Khalid, Forhad Hossain, Khandaker ATM, Marda, Mahesh, Wahab Zubair, MA, Ali, Mohammed Mukarram, Ashraf, N, Basha, Riyaz, Mirza, Shaeq, Ahmed, Shafeeq, Akhtar, Shamim, Ashraf, Syed Mustafa, Haque, Zahirul“…There is a significant burden of pneumococcal disease in India, which can be prevented. Guidelines for preventive measures and adult immunization have been published in India, but the implementation of the guidelines is low. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
883por Sheppard, Carmen, Fry, Norman K., Mushtaq, Shazad, Woodford, Neil, Reynolds, Rosy, Janes, Regina, Pike, Rachel, Hill, Robert, Kimuli, Maimuna, Staves, Peter, Doumith, Michel, Harrison, Timothy, Livermore, David M“…Conjugate vaccines have reduced pneumococcal disease in vaccinated children and unvaccinated adults, but non-vaccine serotypes are of concern, particularly if antibiotic resistant. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
884por Kirkham, Lea-Ann S., Wiertsema, Selma P., Corscadden, Karli J., Mateus, Tulia, Mullaney, Gemma L., Zhang, Guicheng, Richmond, Peter C., Thornton, Ruth B.“…Antibody function, rather than titer, is considered to be a better correlate of protection from pneumococcal disease. Therefore, we compared the capacities of antibodies from otitis-prone (cases) and healthy (controls) children to neutralize pneumolysin, the pneumococcal toxin currently in development as a vaccine antigen, and to opsonize pneumococcal vaccine and nonvaccine serotypes. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
885“…INTRODUCTION: Invasive pneumococcal disease is an uncommon and notifiable disease in Singapore. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
886“…BACKGROUND: Periodic cycles in the serotype-specific incidence of invasive pneumococcal disease have been described but less is known in carriage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
887por Ojal, John, Hammitt, Laura L., Gaitho, John, Scott, J. Anthony G., Goldblatt, David“…Deriving a correlate of protection (CoP) for carriage is important in guiding the future use of extended PCVs as population control of pneumococcal disease by vaccination is now focused principally on its indirect effect. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
888por Shenoy, Anukul T., Brissac, Terry, Gilley, Ryan P., Kumar, Nikhil, Wang, Yong, Gonzalez-Juarbe, Norberto, Hinkle, Whitney S., Daugherty, Sean C., Shetty, Amol C., Ott, Sandra, Tallon, Luke J., Deshane, Jessy, Tettelin, Hervé, Orihuela, Carlos J.“…For over 130 years, invasive pneumococcal disease has been associated with the presence of extracellular planktonic pneumococci, i.e. diplococci or short chains in affected tissues. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
889por Iijima, Shigeo“…In cases of severe invasive pneumococcal disease, a systematic search for Howell-Jolly bodies on blood smears and the presence of asplenia on abdominal imaging are essential for detecting ICA even in the absence of any family history. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
890por Bradshaw, Jessica L., Pipkins, Haley R., Keller, Lance E., Pendarvis, James K., McDaniel, Larry S.“…Since capsule expression was previously thought to be necessary for establishment of invasive pneumococcal disease (IPD), serotype-specific polysaccharide capsules are targeted by currently licensed pneumococcal vaccines. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
891por Visan, Lucian, Rouleau, Nicolas, Proust, Emilie, Peyrot, Loïc, Donadieu, Arnaud, Ochs, Martina“…Currently marketed Streptococcus pneumoniae (Spn) vaccines, which contain polysaccharide capsular antigens from the most common Spn serotypes, have substantially reduced pneumococcal disease rates but have limited coverage. A trivalent pneumococcal protein vaccine containing pneumococcal choline-binding protein A (PcpA), pneumococcal histidine triad protein D (PhtD), and detoxified pneumolysin is being developed to provide broader, cross-serotype protection. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
892por Mostowy, Rafał J., Croucher, Nicholas J., De Maio, Nicola, Chewapreecha, Claire, Salter, Susannah J., Turner, Paul, Aanensen, David M., Bentley, Stephen D., Didelot, Xavier, Fraser, Christophe“…Diversity of the polysaccharide capsule in Streptococcus pneumoniae—main surface antigen and the target of the currently used pneumococcal vaccines—constitutes a major obstacle in eliminating pneumococcal disease. Such diversity is genetically encoded by almost 100 variants of the capsule biosynthesis locus, cps. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
893por Bricio-Moreno, Laura, Ebruke, Chinelo, Chaguza, Chrispin, Cornick, Jennifer, Kwambana-Adams, Brenda, Yang, Marie, Mackenzie, Grant, Wren, Brendan W, Everett, Dean, Antonio, Martin, Kadioglu, Aras“…Streptococcus pneumoniae serotype 1 is one of the leading causes of invasive pneumococcal disease (IPD) in West Africa, with ST618 being the dominant cause of IPD in The Gambia. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
894por Marbaix, Sophie, Peetermans, Willy E., Verhaegen, Jan, Annemans, Lieven, Sato, Reiko, Mignon, Annick, Atwood, Mark, Weycker, Derek“…METHODS: A cohort model was developed to project lifetime risks, consequences, and costs of invasive pneumococcal disease (IPD) and pneumococcal community-acquired pneumonia (CAP). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
895“…CONCLUSIONS: The current study supports the use of the revised CLSI susceptibility breakpoints that promote using penicillin to treat nonmeningeal pneumococcal disease, and might slow the development of resistance to broader-spectrum antibiotics.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
896por Kawakami, Kenji, Kishino, Hiroyuki, Kanazu, Shinichi, Takahashi, Kenichi, Iino, Tomoharu, Sawata, Miyuki, Musey, Luwy“…The optimal interval between the initial vaccination and revaccination with PPSV23 is of interest to protect elderly from pneumococcal disease over the long-term. In this post-hoc analysis, we analyzed that the immunogenicity and safety of revaccination with PPSV23 by time interval after the initial vaccination. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
897por Alvarado, Sylvina, Cavada, Gabriel, Villena, Rodolfo, Wilhelm, Jan, Budnik, Isolda, Lara, Cristian, Salinas, Ximena, Azpilcueta, Nury, Valenzuela, María Teresa“…OBJECTIVE: The objective of this study was to evaluate the impact of the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) on the incidence of invasive pneumococcal disease (IPD) and on community-acquired pneumonia (CAP) in hospitalized children under 5 years of age in the southern area of Santiago, Chile. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
898por Obolski, Uri, Gori, Andrea, Lourenço, José, Thompson, Craig, Thompson, Robin, French, Neil, Heyderman, Robert S., Gupta, Sunetra“…Why some pneumococci invade the bloodstream or CSF (so-called invasive pneumococcal disease; IPD) is uncertain. In this study we identify genes associated with IPD. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
899por van den Biggelaar, Anita H. J., Pomat, William S., Masiria, Geraldine, Wana, Sandra, Nivio, Birunu, Francis, Jacinta, Ford, Rebecca, Passey, Megan, Kirkham, Lea-Ann, Jacoby, Peter, Lehmann, Deborah, Richmond, Peter“…We investigated the immunogenicity, seroprotection rates and persistence of immune memory in young children at high risk of pneumococcal disease in Papua New Guinea (PNG). Children were primed with 10-valent (PCV10) or 13-valent pneumococcal conjugate vaccines (PCV13) at 1, 2 and 3 months of age and randomized at 9 months to receive PPV (PCV10/PPV-vaccinated, n = 51; PCV13/PPV-vaccinated, n = 52) or no PPV (PCV10/PPV-naive, n = 57; PCV13/PPV-naive, n = 48). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
900por Abaye, Gizaw, Fekadu, Hailu, Haji, Kelili, Alemu, Desalegn, Anjulo, Antehun Alemayehu, Yadate, Debela T.“…OBJECTIVE: S. pneumoniae responsible for a range of respiratory infections from uncomplicated to severe invasive pneumococcal disease. Nasopharyngeal specimens were collected from children attending kindergarten and aged ≤ 6 years from February, 2017 to June, 2017 to assess the nasopharyngeal carriage and antimicrobial susceptibility pattern of S. pneumoniae. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto